Sir Run Run Shaw Hospital, Zhejiang University

Hangzhou, Zhejiang 310016

1 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement, Non-Small Cell Lung Cancer, Squamous Non Small Cell Lung Cancer

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC — Completed
• A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC — Status unconfirmed